Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2001-05-22
Original market date: See footnote 1
1997-02-04
Product name:
METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL
DIN:
02170655 Electronic product monograph is not available
Company:
WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada
H4R 1J6
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intra-Arterial , Intrathecal , Intramuscular , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01BA01 METHOTREXATE
Active ingredient group (AIG) number:See footnote5
0107545003
Active ingredient(s) | Strength |
---|---|
METHOTREXATE (METHOTREXATE SODIUM) | 20 MG / VIAL |